Treatment Ready within 7 Days

Following a blood draw, the subject’s blood is fractionated into its components. The stem cells are removed, cultured in the subject’s own blood serum, differentiated into angiogenic cell precursors, and returned to the subject in seven days. The final product is transported to the treating physician in a sterile ready-to-use syringe, which is contained in a temperature controlled environment that provides a stable product for 48-hours.